BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IncobotulinumtoxinA (Xeomin) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of IncobotulinumtoxinA (Xeomin)\, from Clini
 calTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05327972-10441@assetmemo.bio
DTSTAMP:20261121T010016Z
DTSTART;VALUE=DATE:20270228
DTEND;VALUE=DATE:20270301
SUMMARY:IncobotulinumtoxinA (Xeomin): Phase 2 readout est. (NCT05327972)
DESCRIPTION:IncobotulinumtoxinA (Xeomin)\, phase 2.\nStudy: DEgenerative RO
 tator Cuff Disease and Botulinum TOXin\nEstimated primary completion: Febr
 uary 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout
  date\, and it can move.\nDrug page: https://assetmemo.bio/drug/incobotuli
 numtoxina-xeomin#upcoming-events\nRegistry record: https://clinicaltrials.
 gov/study/NCT05327972
URL:https://assetmemo.bio/drug/incobotulinumtoxina-xeomin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05598723-10441@assetmemo.bio
DTSTAMP:20261121T010016Z
DTSTART;VALUE=DATE:20270224
DTEND;VALUE=DATE:20270225
SUMMARY:IncobotulinumtoxinA (Xeomin): Phase 3 readout est. (NCT05598723)
DESCRIPTION:IncobotulinumtoxinA (Xeomin)\, phase 3\, Migraine.\nStudy: BOTO
 X® vs. XEOMIN® for Chronic Migraine\nEstimated primary completion: 24 Fe
 bruary 2027. This is a ClinicalTrials.gov estimate\, not a confirmed reado
 ut date\, and it can move.\nDrug page: https://assetmemo.bio/drug/incobotu
 linumtoxina-xeomin#upcoming-events\nRegistry record: https://clinicaltrial
 s.gov/study/NCT05598723
URL:https://assetmemo.bio/drug/incobotulinumtoxina-xeomin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07018713-10441@assetmemo.bio
DTSTAMP:20261121T010016Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:IncobotulinumtoxinA (Xeomin): Phase 3 readout est. (NCT07018713)
DESCRIPTION:IncobotulinumtoxinA (Xeomin)\, phase 3\, Migraine.\nStudy: A Cl
 inical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Pr
 eventing Chronic Migraine\nEstimated primary completion: March 2027. This 
 is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it c
 an move.\nDrug page: https://assetmemo.bio/drug/incobotulinumtoxina-xeomin
 #upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT070
 18713
URL:https://assetmemo.bio/drug/incobotulinumtoxina-xeomin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07018700-10441@assetmemo.bio
DTSTAMP:20261121T010016Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:IncobotulinumtoxinA (Xeomin): Phase 3 readout est. (NCT07018700)
DESCRIPTION:IncobotulinumtoxinA (Xeomin)\, phase 3\, Migraine.\nStudy: A Cl
 inical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Pr
 eventing Episodic Migraine\nEstimated primary completion: March 2027. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/incobotulinumtoxina-xeomi
 n#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07
 018700
URL:https://assetmemo.bio/drug/incobotulinumtoxina-xeomin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT03977493-10441@assetmemo.bio
DTSTAMP:20261121T010016Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:IncobotulinumtoxinA (Xeomin): Phase 3 readout est. (NCT03977493)
DESCRIPTION:IncobotulinumtoxinA (Xeomin)\, phase 3.\nStudy: Incobotulinumto
 xinA (Xeomin) to Treat Focal Hand Dystonia\nEstimated primary completion: 
 31 December 2027. This is a ClinicalTrials.gov estimate\, not a confirmed 
 readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/inc
 obotulinumtoxina-xeomin#upcoming-events\nRegistry record: https://clinical
 trials.gov/study/NCT03977493
URL:https://assetmemo.bio/drug/incobotulinumtoxina-xeomin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT04908423-10441@assetmemo.bio
DTSTAMP:20261121T010016Z
DTSTART;VALUE=DATE:20280430
DTEND;VALUE=DATE:20280501
SUMMARY:IncobotulinumtoxinA (Xeomin): Phase 4 readout est. (NCT04908423)
DESCRIPTION:IncobotulinumtoxinA (Xeomin)\, phase 4.\nStudy: Xeomin® and Ga
 it Related Mobility After Stroke\nEstimated primary completion: April 2028
 . This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, a
 nd it can move.\nDrug page: https://assetmemo.bio/drug/incobotulinumtoxina
 -xeomin#upcoming-events\nRegistry record: https://clinicaltrials.gov/study
 /NCT04908423
URL:https://assetmemo.bio/drug/incobotulinumtoxina-xeomin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06995287-10441@assetmemo.bio
DTSTAMP:20261121T010016Z
DTSTART;VALUE=DATE:20280609
DTEND;VALUE=DATE:20280610
SUMMARY:IncobotulinumtoxinA (Xeomin): Phase 3 readout est. (NCT06995287)
DESCRIPTION:IncobotulinumtoxinA (Xeomin)\, phase 3.\nStudy: Evaluation of t
 he Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hyste
 roscopy in Pelvic Pain Suggestive of Dysmenorrhea\nEstimated primary compl
 etion: 9 June 2028. This is a ClinicalTrials.gov estimate\, not a confirme
 d readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/i
 ncobotulinumtoxina-xeomin#upcoming-events\nRegistry record: https://clinic
 altrials.gov/study/NCT06995287
URL:https://assetmemo.bio/drug/incobotulinumtoxina-xeomin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07537855-10441@assetmemo.bio
DTSTAMP:20261121T010016Z
DTSTART;VALUE=DATE:20280930
DTEND;VALUE=DATE:20281001
SUMMARY:IncobotulinumtoxinA (Xeomin): Phase 2 readout est. (NCT07537855)
DESCRIPTION:IncobotulinumtoxinA (Xeomin)\, phase 2.\nStudy: Efficacy of Int
 racavernosal Xeomin With Tadalafil for Mild-Moderate Erectile Dysfunction\
 nEstimated primary completion: September 2028. This is a ClinicalTrials.go
 v estimate\, not a confirmed readout date\, and it can move.\nDrug page: h
 ttps://assetmemo.bio/drug/incobotulinumtoxina-xeomin#upcoming-events\nRegi
 stry record: https://clinicaltrials.gov/study/NCT07537855
URL:https://assetmemo.bio/drug/incobotulinumtoxina-xeomin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
